Drs. Jack West & Giorgio Scagliotti discuss the rapid evolution of lung cancer management as well as the practical bottlenecks & challenges limiting the quality of lung cancer care globally.

Drs. Jack West & Alex Drilon, from Memorial Sloan-Kettering, discuss opportunities & challenges of studying narrow molecularly-defined patient subgroups, (MET, RET, TRK, & others), along with the increasingly active role of online patient groups.

Dr. Jack West & guests, Drs. Christine Hann from Johns Hopkins & Stephen Liu from Georgetown, review recent potentially practice-changing results in small cell lung cancer (SCLC) & consider the challenges & future prospects for the SCLC landscape.

Dr. Jack West connects with Dr. Matthew Gubens of UCSF, discussing practicing oncology in the Bay Area, telemedicine in the cancer clinic, emerging data supportig plasma NGS in advanced NSCLC, & struggling to maintain work-life balance.

Drs. Jack West & Joan Schiller discuss explosive changes in treating lung cancer, her role in developing a thriving nonprofit, challenges for women in academic medicine, stigma vs. lung cancer patients, & the growing influence of online patient groups.

Dr. Jack West speaks with thoracic oncology global leader, Dr. David Gandara, on his role in mentoring junior colleagues, the evolution of clinical trials under his leadership of the Lung Cancer Committee of SWOG, & the new opportunities presented by blood-based testing for biomarkers.

Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the evidence on an optimal duration of immunotherapy for long-responding patients with advanced NSCLC, weighing efficacy, potential toxicity, and cost concerns.

Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical trials and delivering increasingly complex patient care, along with the possible future role of artificial intelligence and telemedicine.